A randomized comparison of total-marrow irradiation, Busulfan and cyclophosphamide with tandem high-dose melphalan in patients with multiple myeloma

被引:2
|
作者
Knop, Stefan [1 ]
Bauer, Katja [1 ]
Hebart, Holger [2 ]
Wandt, Hannes [3 ]
Trumper, Lorenz [4 ]
Liebisch, Peter [5 ]
Maschmeyer, Georg [6 ]
Peest, Dietrich [7 ]
Wolf, Hans H. [8 ]
Kroger, Nikolaus [9 ]
Straka, Chrisian [10 ]
Pfreundschuh, Michael [11 ]
Coser, Paolo [2 ,12 ]
Meisner, Christoph
Kanz, Lothar [2 ]
Einsele, Hermann [1 ]
机构
[1] Univ Hosp, Wurzburg, Germany
[2] Univ Hosp, Tubingen, Germany
[3] Klinikum Nord, Nurnberg, Germany
[4] Univ Hosp, Gottingen, Germany
[5] Univ Hosp, Ulm, Germany
[6] Klinikum Potsdam, Potsdam, Germany
[7] Hannover Med Sch, D-3000 Hannover, Germany
[8] Univ Hosp, Halle, Germany
[9] Univ Hamburg Hosp, D-2000 Hamburg, Germany
[10] Univ Hosp, Munich, Germany
[11] Univ Hosp, Homburg, Germany
[12] Reg Hosp, Bolzano, Italy
关键词
D O I
10.1182/blood.V110.11.728.728
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
728
引用
收藏
页码:223A / 224A
页数:2
相关论文
共 50 条
  • [1] Total Marrow Irradiation, Busulfan, and Cyclophosphamide Is Equivalent to Tandem Melphalan in Myeloma
    Knop, S.
    Neveling, K.
    Hebart, H.
    Wandt, H.
    Truemper, L.
    Liebisich, P.
    Maschmeyer, G.
    Peest, D.
    Wolf, H. H.
    Kroger, N.
    Straka, C.
    Pfreundschuh, M.
    Coser, P.
    Kanz, L.
    Einsele, H.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S73 - S74
  • [2] Comparison of high-dose melphalan with a more intensive regimen of thiotepa, busulfan, and cyclophosphamide for patients with multiple myeloma
    Anagnostopoulos, A
    Aleman, A
    Ayers, G
    Donato, M
    Champlin, R
    Weber, D
    Alexanian, R
    Giralt, S
    CANCER, 2004, 100 (12) : 2607 - 2612
  • [3] Tandem autologous hematopoietic cell transplantation with sequential use of total marrow irradiation and high-dose melphalan in multiple myeloma
    Sebastian Giebel
    Małgorzata Sobczyk-Kruszelnicka
    Sławomir Blamek
    Maria Saduś-Wojciechowska
    Jacek Najda
    Tomasz Czerw
    Włodzimierz Mendrek
    Grzegorz Woźniak
    Bożena Jochymek
    Michał Radwan
    Wojciech Leszczyński
    Łukasz Dolla
    Andrea D’Amico
    Krzysztof Ślosarek
    Jerzy Hołowiecki
    Leszek Miszczyk
    Bone Marrow Transplantation, 2021, 56 : 1297 - 1304
  • [4] Tandem autologous hematopoietic cell transplantation with sequential use of total marrow irradiation and high-dose melphalan in multiple myeloma
    Giebel, Sebastian
    Sobczyk-Kruszelnicka, Malgorzata
    Blamek, Slawomir
    Sadus-Wojciechowska, Maria
    Najda, Jacek
    Czerw, Tomasz
    Mendrek, Wlodzimierz
    Wozniak, Grzegorz
    Jochymek, Bozena
    Radwan, Michal
    Leszczynski, Wojciech
    Dolla, Lukasz
    D'Amico, Andrea
    Slosarek, Krzysztof
    Holowiecki, Jerzy
    Miszczyk, Leszek
    BONE MARROW TRANSPLANTATION, 2021, 56 (06) : 1297 - 1304
  • [5] Total marrow irradiation, busulfan and cyclophosphamide followed by PBSCT in patients with multiple myeloma.
    Einsele, H
    Bamberg, M
    Zander, A
    Kröger, N
    Budach, W
    Schmidt, H
    Schmidberger, H
    Hebart, H
    Trümper, L
    Müller, W
    Schlimok, G
    Hertenstein, B
    Peest, D
    Metzner, B
    Frickhofen, N
    Kanz, L
    BLOOD, 1998, 92 (10) : 128A - 128A
  • [6] Total marrow irradiation, busulfan and cyclophosphamide followed by PBSCT in patients with multiple myeloma.
    Einsele, H
    Bamberg, M
    Schmidt, H
    Schmidberger, H
    Trümper, L
    Müller, G
    Oruzio, A
    Hertenstein, B
    Peest, D
    Metzner, B
    Frickhofen, N
    Kanz, L
    BONE MARROW TRANSPLANTATION, 1999, 23 : S134 - S134
  • [7] A Phase 1 Study of Total Marrow Irradiation Combined with High-Dose Melphalan for Patients with Relapsed/Refractory Multiple Myeloma
    Patel, Pritesh R.
    Oh, Annie L.
    Koshy, Matthew
    Aydogan, Bulent
    Sweiss, Karen
    Quigley, John G.
    Saraf, Santosh L.
    Khan, Irum
    Hacker, Eileen D.
    Mahmud, Nadim
    Peace, David J.
    Ozer, Howard
    Windhorst, Jennifer
    Weichselbaum, Ralph R.
    Rondelli, Damiano
    BLOOD, 2016, 128 (22)
  • [8] Total Marrow Irradiation Combined with High-Dose Melphalan for Patients with Relapsed/Refractory Multiple Myeloma: A Phase 1 Study
    Patel, Pritesh Rajni
    Oh, Annie
    Koshy, Matthew
    Sweiss, Karen
    Saraf, Santosh
    Quigley, John
    Khan, Irum
    Mahmud, Nadim
    Hacker, Eileen Danaher
    Ozer, Howard
    Peace, David
    Weichselbaum, Ralph R.
    Aydogan, Bulent
    Rondelli, Damiano
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S67 - S67
  • [9] Dose-Escalated Total-Marrow Irradiation (TMI) for Relapsed Multiple Myeloma
    Samant, R.
    Tay, J.
    Nyiri, B.
    Carty, K.
    Gerig, L.
    Andrusyk, S.
    Montgomery, L.
    Atkins, H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E65 - E66
  • [10] Total marrow irradiation (TMI) with helical tomotherapy and PBPC following high-dose melphalan and PBPC as part of tandem therapy for patients with multiple myeloma.
    Somlo, G
    Forman, S
    Poppelwell, L
    Schultheiss, T
    Frankel, P
    Krishnan, A
    Liu, A
    Sahebi, F
    Pablo, P
    Wong, J
    BLOOD, 2005, 106 (11) : 343A - 344A